Not a very exciting stock (extremely low volume), but seems to have excellent support at these levels. Bought @ $5 (luckily) a while back and will tuck it away and forget about it for several years - hopefully for a nice surprise... Good news will come out of this company and the volume will double this stock real fast. (IMO)
They were one of the few companies with balls to have an IPO under these market conditions. That tells me something... What, I don't know...
Agree on it not being too exciting at the moment but it's good to be in this under the IPO price. I've owned some interesting biotechs in the past (CERS, CBST, CLSR) but let them go way too soon. In a good market these things will sometimes run strong just on anticipation alone, but most will fall just as fast until they start showing some successful product. SGEN definitely has their sights on the right targets but unfortunately for the stockholders so do a lot of other companies. IMGN seems to be our closest competitor. The FDA will expedite the approval process for which ever gets there first or looks best. The world can't get these cures too soon. Let's hope we're the leader of the pack.
Motley Fool has some discussion boards on biotech but you have to register to read them. Hopefully in a year we'll wish we had twice as many shares.